What are Prostaglandin E2 analog drugs?

Prostaglandin E2 analog drugs are pharmacologic agents that share a common mechanism (typically targeting Prostaglandin E receptors (EP1, EP3)). 1 are currently marketed, with 3 more in clinical development.

What are the marketed Prostaglandin E2 analog drugs?

Marketed Prostaglandin E2 analog drugs include Dinoprostone vaginal insert.

Prostaglandin E2 analog

1 marketed 3 in Phase 3

This page covers all Prostaglandin E2 analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Prostaglandin E receptors (EP1, EP3), Prostaglandin E receptor (EP receptors), Prostaglandin E receptor (EP receptor).

Targets

Prostaglandin E receptors (EP1, EP3) · Prostaglandin E receptor (EP receptors) · Prostaglandin E receptor (EP receptor)

Marketed (1)

Dinoprostone vaginal insert · HaEmek Medical Center, Israel · Obstetrics
Dinoprostone is a prostaglandin E2 analog that binds to prostaglandin receptors to stimulate uterine contractions and promote cervical ripening and labor induction.

Phase 3 pipeline (3)

Prostin E2 · Ain Shams University · Obstetrics
Prostin E2 (dinoprostone) is a prostaglandin E2 analog that binds to prostaglandin E receptors to promote uterine contractions and cervical ripening.
Propess,SYNPITAN FORT · Erzincan Military Hospital · Obstetrics
Propess is a sustained-release dinoprostone (prostaglandin E2) vaginal insert that promotes cervical ripening and uterine contractions to induce labor.
Administration of Propess · Tel-Aviv Sourasky Medical Center · Obstetrics
Propess is a vaginal insert that delivers dinoprostone (prostaglandin E2) directly to the cervix to promote cervical ripening and labor induction.